PDK1 and melanoma: Potentially relevant proteins include MEK1/2 (8% of melanomas), involved in the MAPK-pathway [25], and mTOR (10.4% of primary melanomas) or PDK1, involved in the PI3K-Akt-mTOR pathway [28, 29].